Pharmacological characterisation of the presynaptic alpha-adrenoceptor in the rat vas deferens

European Journal of Pharmacology
G M Drew

Abstract

The interactions between alpha-adrenoceptor agonists and antagonists on the twitch response of the rat isolated vas deferens to low frequency motor nerve stimulatioh have been examined. Oxymetazoline, clonidine, naphazoline and BAY-1470 caused a concentration-dependent inhibition of the twitch response at concentrations lower than those causing smooth muscle stimulation. The twitch-inhibitory effect of these compounds is thought to result from stimulation of presynaptically located alpha-adrenoceptors. In contrast, phenylephrine and methoxamine exerted little inhibitory effect at concentrations less than those which produced postsynaptic stimulation. The inhibitory effect of clonidine was antagonised by phentolamine, piperoxan, yohimbine and tolazoline, but not by thymoxamine. These results characterise the presynaptic alpha-adrenoceptors in the rat vas deferens as being of the same type as those present in the rabbit pulmonary artery and rat heart, but different from those located post-synaptically in sympathetically innervated tissues.

References

Nov 3, 1975·Naunyn-Schmiedeberg's Archives of Pharmacology·K StarkeH D Taube
Mar 1, 1975·British Journal of Pharmacology·M E Jones, T L Spriggs
Dec 1, 1975·European Journal of Pharmacology·K StarkeT Endo
Jun 20, 1975·Naunyn-Schmiedeberg's Archives of Pharmacology·M A Enero, S Z Langer
Jan 1, 1971·Naunyn-Schmiedebergs Archiv Für Pharmakologie·K StarkeH J Schümann
Jul 1, 1965·The Journal of Pharmacy and Pharmacology·A T Birmingham, J Szolcsányi
Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·K Starke
Dec 1, 1973·British Journal of Pharmacology·J Hughes
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Dec 1, 1960·British Journal of Pharmacology and Chemotherapy·H BoydM J Rand

Citations

Nov 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·A T Sullivan, G M Drew
Aug 1, 1981·Naunyn-Schmiedeberg's Archives of Pharmacology·N B SheppersonS Z Langer
Jun 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·D J PettiboneJ J Baldwin
Dec 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·B CostallC C Tan
Jan 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·K HondaK Shiono
Jan 1, 1981·European Journal of Clinical Pharmacology·T KawasakiT Omae
Dec 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·R P McAdams, J F Waterfall
Aug 15, 1977·European Journal of Pharmacology·J M Cedarbaum, G K Aghajanian
Jul 1, 1978·European Journal of Pharmacology·D P WestfallJ N Rowe
Dec 1, 1978·European Journal of Pharmacology·M Butler, D H Jenkinson
Apr 1, 1979·European Journal of Pharmacology·P B TimmermansP A Van Zwieten
Sep 1, 1979·European Journal of Pharmacology·J LeightonL L Parmeter
Dec 17, 1982·European Journal of Pharmacology·P L McLennan, G A Bentley
Jan 21, 1983·European Journal of Pharmacology·A M French, N C Scott
Dec 17, 1985·European Journal of Pharmacology·M L Vargas, A J Brugger
Dec 1, 1987·European Journal of Pharmacology·L BrasiliW Quaglia
Jul 4, 1996·European Journal of Pharmacology·N H JurkiewiczA Jurkiewicz
Jan 1, 1980·The International Journal of Biochemistry·E D SaggersonC A Carpenter
Jun 24, 2003·Il Farmaco·Dario GiardinàA Leonardi
Apr 20, 1999·Pharmacology, Biochemistry, and Behavior·A M Montgomery, A J Grottick
Jan 1, 1978·British Journal of Pharmacology·I MarshallN B Shepperson
Dec 1, 1978·British Journal of Pharmacology·W HopeD F Story
Mar 1, 1979·British Journal of Pharmacology·D A Brown, M P Caulfield
Oct 1, 1979·British Journal of Pharmacology·G M Drew, S B Whiting
Apr 1, 1991·British Journal of Pharmacology·I AkersA T Sullivan
Nov 1, 1993·British Journal of Pharmacology·F OralloM I Cadavid
Jan 1, 1979·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·A F GreenI L Natoff
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·T TakenakaH Maeno
Mar 1, 1986·Journal of Autonomic Pharmacology·J A Leedham, J N Pennefather
Mar 12, 2002·Bioorganic & Medicinal Chemistry·Dario GiardinàCarlo Melchiorre
Jan 13, 2000·Bioorganic & Medicinal Chemistry·N CinoneA Carotti
Dec 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·V RaviprakashJ N Panda
Jan 1, 1982·The Journal of Pharmacy and Pharmacology·M G WyllieJ Fox
Apr 1, 1982·The Journal of Pharmacy and Pharmacology·A BadiaF Jané
Jun 1, 1982·The Journal of Pharmacy and Pharmacology·H A SahyounR J Naylor
Jul 1, 1983·British Journal of Pharmacology·K G Digges, R J Summers
Jan 1, 1985·Journal of Receptor Research·H F Miranda, W W Wolstenholme
Jul 1, 1983·Clinical and Experimental Pharmacology & Physiology·J N Pennefather
Apr 1, 1982·Acta Pharmacologica Et Toxicologica·J E WikbergR G Andersson
Aug 1, 1978·The Journal of Pharmacy and Pharmacology·K F Rhodes, J F Waterfall
May 1, 1979·The Journal of Pharmacy and Pharmacology·H Kapur, D R Mottram
Sep 1, 1989·The Journal of Pharmacy and Pharmacology·A Badia, J Sallés
Dec 1, 1981·British Journal of Pharmacology·P DemichelJ Roquebert
Dec 1, 1983·British Journal of Pharmacology·A M French, N C Scott
Nov 1, 1984·The Journal of Pharmacy and Pharmacology·C Ennis, N Lattimer

Related Concepts

Adrenergic alpha-Agonists
Adrenergic alpha-Antagonists
Metazoa
Isoglaucon
Electric Stimulation Technique
Inotropism
Norepinephrine Receptors
Alpha-adrenergic receptor
Vas Deferens Structure
Rats, Laboratory

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.